help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Natarajan, R.
Right arrow Articles by Nadler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Natarajan, R.
Right arrow Articles by Nadler, J.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 6 1790-1798
Copyright © 1997 by The Endocrine Society

Endocrinological Oncology

Increased 12-Lipoxygenase Expression in Breast Cancer Tissues and Cells. Regulation by Epidermal Growth Factor1

Rama Natarajan, Robert Esworthy, Wei Bai, Jia-Li Gu, Sharon Wilczynski and Jerry Nadler

Departments of Diabetes, Endocrinology and Metabolism, (R.N., W.B., J.G., J.N.) Medical Oncology (R.E.) and Anatomic Pathology (S.W.), City of Hope National Medical Center, Duarte, California 91010

Address all correspondence and requests for reprints to: Jerry Nadler, M.D., Department of Diabetes and Endocrinology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, California 91010. E-mail: jnadler{at}smtplink.coh.org

The interaction of growth factors, such as epidermal growth factor (EGF) with their receptors, on breast cancer cells can lead to the hydrolysis of phospholipids and release of fatty acids, such as arachidonic acid, which can be further metabolized by the lipoxygenase (LO) pathway. Several LO products have been shown to stimulate oncogenes and have mitogenic and chemotactic effects. In this study, we have evaluated the regulation of 12-LO activity and expression in breast cancer cells and tissues. Leukocyte-type 12-LO messenger RNA (mRNA) expression was studied by a specific RT-PCR method in matched, normal, uninvolved and cancer-involved breast tissue RNA samples from six patients. In each of these six patients, the cancer-involved section showed a much higher level of 12-LO mRNA than the corresponding normal section. 12-LO mRNA levels also were greater in two breast cancer cell lines, MCF-7 and COH-BR1, compared with the nontumorigenic breast epithelial cell line, MCF-10F. The growth of the MCF-7 cells was significantly inhibited by two specific LO blockers but not by a cyclooxygenase blocker. Treatment of serum-starved MCF-7 cells with EGF for 4 h led to a dose-dependent increase in the formation of the 12-LO product, 12-hydroxyeicosatetraenoic acid. EGF treatment also increased the levels of the leukocyte-type 12-LO protein expression at 24 h. These results suggest that activation of the 12-LO pathway may play a key role in basal and EGF-induced breast cancer cell growth.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
R. Castilla, M. Gadaleta, A. F. Castillo, A. Duarte, I. Neuman, C. Paz, F. Cornejo Maciel, and E. J. Podesta
New Enzymes Involved in the Mechanism of Action of Epidermal Growth Factor in a Clonal Strain of Leydig Tumor Cells
Endocrinology, July 1, 2008; 149(7): 3743 - 3752.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. R. Preston, N. S. Hill, R. R. Warburton, and B. L. Fanburg
Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L367 - L374.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. A. Nony, S. B. Kennett, W. C. Glasgow, K. Olden, and J. D. Roberts
15(S)-Lipoxygenase-2 Mediates Arachidonic Acid-stimulated Adhesion of Human Breast Carcinoma Cells through the Activation of TAK1, MKK6, and p38 MAPK
J. Biol. Chem., September 9, 2005; 280(36): 31413 - 31419.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. P. Pidgeon, K. Tang, Y. L. Cai, E. Piasentin, and K. V. Honn
Overexpression of Platelet-type 12-Lipoxygenase Promotes Tumor Cell Survival by Enhancing {alpha}v{beta}3 and {alpha}v{beta}5 Integrin Expression
Cancer Res., July 15, 2003; 63(14): 4258 - 4267.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Graham. P. Pidgeon, M. Kandouz, A. Meram, and K. V. Honn
Mechanisms Controlling Cell Cycle Arrest and Induction of Apoptosis after 12-Lipoxygenase Inhibition in Prostate Cancer Cells
Cancer Res., May 1, 2002; 62(9): 2721 - 2727.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. C. Y. Wong, W. P. Wang, C. H. Cho, X. M. Fan, M. C. M. Lin, H. F. Kung, and S. K. Lam
12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells
Carcinogenesis, September 1, 2001; 22(9): 1349 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. A. Williams and D. H. Phillips
Mammary Expression of Xenobiotic Metabolizing Enzymes and Their Potential Role in Breast Cancer
Cancer Res., September 1, 2000; 60(17): 4667 - 4677.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
V. E. Steele, C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, and G. J. Kelloff
Lipoxygenase Inhibitors as Potential Cancer Chemopreventives
Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 467 - 483.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society